Abvc Biopharma (ABVC) Operating Income (2016 - 2025)
Historic Operating Income for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to -$1.2 million.
- Abvc Biopharma's Operating Income fell 28648.63% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 772.18%. This contributed to the annual value of -$4.7 million for FY2024, which is 3046.51% up from last year.
- Latest data reveals that Abvc Biopharma reported Operating Income of -$1.2 million as of Q3 2025, which was down 28648.63% from -$2.3 million recorded in Q2 2025.
- Over the past 5 years, Abvc Biopharma's Operating Income peaked at -$302316.0 during Q3 2024, and registered a low of -$6.4 million during Q4 2021.
- For the 5-year period, Abvc Biopharma's Operating Income averaged around -$2.2 million, with its median value being -$2.0 million (2021).
- As far as peak fluctuations go, Abvc Biopharma's Operating Income plummeted by 39640.76% in 2022, and later soared by 8597.06% in 2024.
- Abvc Biopharma's Operating Income (Quarter) stood at -$6.4 million in 2021, then surged by 51.41% to -$3.1 million in 2022, then surged by 83.66% to -$511835.0 in 2023, then crashed by 37.65% to -$704564.0 in 2024, then tumbled by 65.83% to -$1.2 million in 2025.
- Its last three reported values are -$1.2 million in Q3 2025, -$2.3 million for Q2 2025, and -$693005.0 during Q1 2025.